SCHEMBL7842489

SCHEMBL7842489

CCOC(=O)C(c1ccc2c(c1)OCO2)C(C=O)c1ccc(Br)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
HTT P42858 2/20 0.44
KDM4E B2RXH2 3/20 0.44
HPGD P15428 3/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 3/20 0.43
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
KMT2A Q03164 2/20 0.41
OGA O60502 2/20 0.41
TSHR P16473 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 1/20 0.40
MCHR1 Q99705 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7841290 0.91 RAB9A (0.46) RAB9ANPC1CYP1A2CYP3A4CYP2D6
SCHEMBL7831716 0.89 RAB9A (0.44) RAB9ANPC1CYP1A2CYP3A4CYP2D6
SCHEMBL7839027 0.89 KDM4E (0.49) RAB9ANPC1CYP1A2CYP3A4CYP2D6
SCHEMBL7838582 0.88 MAPT (0.55) RAB9ANPC1CYP1A2CYP3A4CYP2D6
SCHEMBL8152135 0.88 KMT2A (0.57) RAB9ANPC1CYP1A2CYP3A4CYP2D6
SCHEMBL27378630 0.87 CYP3A4 (0.43) RAB9ANPC1CYP1A2CYP3A4CYP2D6
SCHEMBL7842082 0.87 NPC1 (0.44) RAB9ANPC1CYP1A2CYP3A4CYP2D6
SCHEMBL7843720 0.87 KDM4E (0.44) RAB9ANPC1CYP1A2CYP3A4CYP2D6
SCHEMBL7840091 0.86 CRHBP (0.47) RAB9ANPC1CYP1A2CYP3A4CYP2D6
SCHEMBL7839857 0.86 KDM4E (0.43) RAB9ANPC1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1072660-C 2,1,3-benzothia (oxa) diazole derivatives having an endothelin receptor antagonistic effect MERCK PATENT GMBH (DE) 2001-10-10 CN disclosed
EP-0882030-B1 2,1,3-BENZOTHIA(OXA)DIAZOLE DERIVATIVES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT MERCK PATENT GMBH (DE) 2001-09-12 EP disclosed
US-6017939-A 2,1,3-benzothia(OXA)diazole derivatives having an endothelin receptor antagonistic effect MERCK PATENT GESELLSCHAFT (DE) 2000-01-25 US disclosed
CN-1216540-A 2,1,3-benzothia (oxa) diazole derivatives having an endothelin receptor antagonistic effect MERCK PATENT GES MIT BESCHRIKT (DE) 1999-05-12 CN disclosed
EP-0882030-A1 2,1,3-BENZOTHIA(OXA)DIAZOLE DERIVATIVES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT MERCK PATENT GmbH (DE) 1998-12-09 EP disclosed
WO-1997030982-A1 2,1,3-BENZOTHIA(OXA)DIAZOLE DERIVATIVES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1997-08-28 WO disclosed